BioAdvance
Status
ACTIVE
Global HQ
Pennsylvania, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
Industries
- Manufacturing
- Pharma
- Diagnostics
- Biotechnology
- Medical Devices
- Digital Health
About
BioAdvance is a venture capital firm that invests in therapies, medical devices, research tools, diagnostics, and health IT in the Mid Atlantic region. They collaborate with entrepreneurs to develop strong companies focused on enhancing human health.
BioAdvance is a venture capital firm that invests in therapies, medical devices, research tools, diagnostics, and health IT in the Mid Atlantic region. They collaborate with entrepreneurs to develop strong companies focused on enhancing human health.
Investment Thesis
BioAdvance focuses on providing early stage capital to companies developing technologies to improve human health. Their investments emphasize therapeutic agents, platform technologies, research tools, medical devices, diagnostics, and healthcare IT.
Manager's Experience
With a robust portfolio, the fund manager has executed over 20 investments across North America and Europe, focusing primarily on healthcare and technology sectors. Backed by a wealth of experience, they have successfully navigated multiple stages of investment, emphasizing early to growth-stage opportunities. A proven strategist, they have achieved noteworthy exits, establishing a track record of delivering substantial returns. Their approach integrates market insights and a keen understanding of industry trends, positioning them as a key player in the investment landscape.
Team
Shahram Hejazi
Gregory Harriman
Susan Willar
Robert Driscoll
Marnie Mccoy
Leonardo Colares
Kim Ferreira
Kim Ellis
Jeff Edelson